Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline Dyadic International Inc DYAI Q1 2026 Earnings EPS Misses Estimates as PreRevenue Status Continues FOSL Q1 2026 Earnings BetterThanExpected Loss Fails to Rally Investors SSSSL Q1 2026 Earnings Stellar EPS Surprise Driven by Strong Investment Gains CVCO Q1 2026 Earnings EPS Beats Estimates Amid Solid Housing Demand DXC Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 293